Artificial intelligence (AI) assessments of chest X-rays identified 28 percent of a 17,000 plus cohort of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.
In a large study of never-smokers, researchers found that artificial assessment of routine chest X-rays identified a high risk of lung cancer in 28 percent of patients who had over double the risk of those deemed to have low risk.
For the study, which will be presented at the annual Radiological Society of North America (RSNA) conference next week in Chicago, researchers evaluated the capability of a deep learning model to assess lung cancer risk based on routine outpatient chest X-rays from 17,407 never-smokers (mean age of 63).
The deep learning model detected a high risk for lung cancer in 28 percent of the cohort and 2.9 percent of these patients were subsequently diagnosed with lung cancer, according to the study authors.
"This AI tool opens the door for opportunistic screening for never-smokers at high risk of lung cancer, using existing chest X-rays in the electronic medical record," said senior study author Michael T. Lu, M.D., M.P.H., the director of artificial intelligence and co-director of the Cardiovascular Imaging Research Center (CIRC) at Massachusetts General Hospital (MGH). "Since cigarette smoking rates are declining, approaches to detect lung cancer early in those who do not smoke are going to be increasingly important."
Never-smokers have 10 to 20 percent of lung cancers diagnosed in the United States, according to the American Cancer Society. This study’s high-risk group with subsequent lung cancer diagnosis in 2.9 percent of patients more than doubled the 1.3 percent six-year risk threshold for the use of CT lung cancer screening as recommended by the National Comprehensive Cancer Guidelines, according to the study authors.
However, as the researchers pointed out, screening guidelines are geared to current smokers or those who have smoked heavily in the past.
"Current Medicare and USPSTF guidelines recommend lung cancer screening CT only for individuals with a substantial smoking history. However, lung cancer is increasingly common in never-smokers and often presents at an advanced stage,” noted lead study author Anika S. Walia, B.A., a researcher at the CIRC at MGH and medical student at the Boston University School of Medicine.
(Editor’s note: For related content, see “FDA Clears AI-Powered Software for Lung Nodule Detection on X-Rays,” “Can Deep Learning Enhance Pulmonary Nodule Detection on Chest X-Rays?” and “Study: AI Assessment of Chest CT May Predict Multiple Mortality Risks.”)
In their research, the study authors also found that the high-risk patients identified with the deep learning model had more than double the risk of low-risk patients even after adjustments for conditions such as chronic obstructive pulmonary disease (COPD) and prior lower respiratory tract infection, and factors such as age, race, and sex.
The study authors noted that development of the deep learning model was based on a total of 147,497 chest X-rays from a cohort of 40,643 asymptomatic smokers and never-smokers from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.